# US 2012/0252098 A1 · Dissociation of Product-complexed Contaminants in Chromatography

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252098 A1
- Document ID: US20120252098A1
- Status: Published application
- Kind: A1
- Application number: 13/237,294
- Filed: 2011-09-20
- Published: 2012-10-04
- Earliest claimed: 2010-09-20
- Assignees: Bio-Rad Laboratories, Inc.
- Inventors: Peter S. Gagnon
- Web page: https://patentgrep.com/patent/US20120252098A1

## CPC

- C07K 1/18: Ion-exchange chromatography
- B01D 15/362: {Cation-exchange}
- B01D 15/3828: {Ligand exchange chromatography, e.g. complexation, chelation or metal interaction chromatography}
- C07K 1/22: Affinity chromatography or related techniques based upon selective absorption processes
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)

## Abstract

The invention provides methods and materials for using apatite chromatography supports to dissociate and remove contaminants that are complexed to biological products. The invention further provides materials and methods for dissociating aggregations of target biological molecules or improperly folded target molecules to improve purification of the target molecule.

## Claims

### Claim 1

A method of purifying a target molecule from a biological sample, the method comprising in the following order,
(a) contacting the sample comprising the target molecule and complexed contaminants to a metal cation-derivatized apatite solid support or a polycation-derivatized apatite solid support, thereby non-covalently binding the target molecule (“the bound target molecule”) to the solid support;
(b) washing the bound target molecule with an agent(s) that displaces the complexed contaminants from the target molecule under conditions in which the target molecule remains substantially bound to the solid support; and (c) eluting the target molecule from the solid support, wherein the eluted target molecule is substantially free of complexed contaminants.

### Claim 2 (depends on 1)

The method of claim 1, comprising washing the agent(s) from the solid support prior to the eluting step.

### Claim 3 (depends on 1)

The method of claim 1, comprising converting the metal cation-derivatized apatite solid support or polycation-derivatized apatite solid support to a non-derivatized apatite between the washing step (b) and the eluting step (c) such that the solid support is a non-derivatized apatite solid support during the eluting step (c).

### Claim 4 (depends on 1)

The method of claim 1, wherein the solid support is a metal cation-derivatized apatite solid support or a polycation-derivatized apatite solid support during the eluting step (c).

### Claim 5 (depends on 1)

The method of claim 1, wherein the apatite is hydroxyapatite or fluorapatite.

### Claim 6 (depends on 5)

The method of claim 5, wherein the apatite is selected from the group consisting of hydroxyapatite CHT Type I, 20 micron; hydroxyapatite CHT Type I, 40 micron; hydroxyapatite CHT Type I, 80 micron; hydroxyapatite CHT Type II, 20 micron; hydroxyapatite CHT Type II, 40 micron; hydroxyapatite CHT Type II, 80 micron; fluorapatite CFT Type I, 40 micron; and fluorapatite CFT Type II, 40 micron.

### Claim 7 (depends on 1)

The method of claim 1, wherein the target molecule is selected from a protein, antibody, phosphoprotein, virus, virus-like particle, or nucleic acid.

### Claim 8 (depends on 7)

The method of claim 7, wherein the target molecule is an antibody.

### Claim 9 (depends on 7)

The method of claim 7, wherein the nucleic acid is DNA or RNA.

### Claim 10 (depends on 1)

The method of claim 1, wherein the complexed contaminants are selected from the group consisting of protein, nucleic acids, lipids, metal ions, sulfides, polysaccharides, and endotoxins.

### Claim 11 (depends on 1)

The method of claim 1, wherein the agent is selected from the group consisting of arginine, urea, guanidine, sodium chloride, a salt lacking significant calcium affinity, an organic solvent, a surfactant, and a reducing agent.

### Claim 12 (depends on 11)

The method of claim 11, wherein the organic solvent is selected from the group consisting of ethylene glycol, propylene glycol, an alcohol, DMSO, and DMF.

### Claim 13 (depends on 11)

The method of claim 11, wherein the surfactant is selected from the group consisting of a polysorbate surfactant, a Triton surfactant, a CHAPS surfactant, a CHAPSO surfactant, and octaglucoside.

### Claim 14 (depends on 11)

The method of claim 11, wherein the reducing agent is selected from the group consisting of a cysteine, DTT, DTE, or mercaptoethanol.

### Claim 15 (depends on 1)

The method of claim 1, wherein the washing step (b) comprises contacting the solid support binding the target molecule with a solution comprising two or more different agents that displace the complexed contaminants.

### Claim 16 (depends on 15)

The method of claim 15, wherein the two or more different agents comprise:
i. urea and sodium chloride;
ii. urea and sodium chloride and cysteine;
iii. a salt and an organic solvent; or
iv. a salt and a surfactant.

### Claim 17 (depends on 1)

The method of claim 1, wherein the metal cation is selected from the group consisting of magnesium, zinc, iron, calcium, nickel, cobalt, manganese, copper, and chromium.

### Claim 18 (depends on 17)

The method of claim 17, wherein the metal cation is calcium.

### Claim 19 (depends on 1)

The method of claim 1, wherein the complexed contaminants are non-covalently complexed with the target molecule.

### Claim 20 (depends on 1)

The method of claim 1, wherein the complexed contaminants are covalently complexed with the target molecule.

### Claim 21 (depends on 1)

The method of claim 1, wherein the complexed contaminants are covalently complexed with the target molecule via a disulfide bond and wherein said agents in the washing step (b) comprise a reducing agent in combination with at least one agent other than a reducing agent, thereby reducing the disulfide bond.

### Claim 22 (depends on 1)

The method of claim 1, wherein the target molecule is eluted from the solid support while the complexed contaminants are bound to the solid support.

### Claim 23 (depends on 1)

The method of claim 1, wherein the target molecule is eluted from the solid support after the complexed contaminants are eluted from the solid support.

### Claim 24 (depends on 23)

The method of claim 23, wherein the target molecule is a nucleic acid and the contaminants comprise non-nucleic acid molecules.

### Claim 25 (depends on 1)

The method of claim 1, wherein the target molecule is a protein and the contaminants comprise non-protein molecules.

### Claim 26 (depends on 1)

The method of claims 1, wherein the target molecule is a protein and the contaminants comprise a protein other than the target molecule protein.

### Claim 27 (depends on 1)

The method of claim 1, wherein the target molecule is a virus or virus-like particle and the contaminants comprise non-virus molecules.
